Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
LAMISIL AT SOLUTION |
| Manufacturer |
|
Novartis Consumer Health |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Allylamine antifungal. |
| Generic Name |
|
Terbinafine HCl 1%. |
| Also |
• LAMISIL AT CREAM
• LAMISIL SOLUTION
|
| Indications |
|
Tinea pedis (interdigital), t. corporis, t. cruris. |
| Children |
|
Not recommended. |
| Adults |
|
Use for 1 week. T. pedis (interdigital): apply twice daily (AM & PM). T. corporis, t. cruris: apply once daily. |
| Precautions |
|
Avoid eyes, nose, mouth, other mucous membranes, scalp, nails, and use of occlusive dressings. Do not use soln spray on face. Discontinue if irritation or sensitivity develops. Pregnancy (Cat.B). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Local irritation, burning, itching, dryness. Soln: also skin exfoliation, erythmatous rash. |
| How Supplied |
Soln—30mL (pump spray)
Crm—12g, 24g
AT Soln—30mL (pump spray or dropper) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
